Jeffrey Joon-Bum So, MS, PA-C

Jeffrey So practices at Golden State Dermatopathology in Walnut Creek, California.

Jeffrey So's NPI, 1659600799, was assigned on December 21, 2009. Jeffrey So holds California license PA20727.

Jeffrey So's primary practice is Golden State Dermatopathology, at 370 N Wiget Ln, Ste 250, Walnut Creek, CA 94598. The practice phone is (925) 278-7592.

Jeffrey So's primary practice is Golden State Dermatopathology in Walnut Creek, California. The medical group on file is Golden State Dermatology. Dmand AI also links Jeffrey So to 1 more group practice or clinic, named with a free account. Jeffrey So's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Jeffrey So practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Jeffrey So's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Jeffrey So is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Jeffrey So is licensed in California.

Dmand AI lists ankle or foot injury, benign or precancerous skin growths, contact dermatitis, head wound, joint cyst, scalp rash, skin cyst and skin discoloration among the conditions Jeffrey So treats.

CMS data shows 1,318 Medicare services from Jeffrey So across 9 procedure codes in 2024, for 448 Medicare patients. Medicare paid $46,615 for them. Every service was in an office.

CMS counts 448 Medicare patients who saw Jeffrey So in 2024. The largest group is 75 to 84, with 189 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jeffrey So's median patient age at 53, with 53% women.

In 2024, Jeffrey So wrote 204 Medicare Part D claims for 132 patients. 95% of them were for generic drugs. CMS names the drug for 106 of them, across 4 drugs with 11 or more claims each, at $1,865 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Jeffrey So for performance year 2024, reported as part of a group. Jeffrey So accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 180 general payments to Jeffrey So from 29 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 98% of the total. Bristol-Myers Squibb Company paid the most, $979.